Call for joint proposals with QBI
QBI and ZNZ are again inviting submissions for the 2023 joint pilot grant round. […]
QBI and ZNZ are again inviting submissions for the 2023 joint pilot grant round. […]
Mehmet Fatih Yanik from the Institute of Neuroinformatics at ETH Zurich and UZH has won a Bridge Discovery Award. Yanik and his team recently developed a novel technology for non-invasive focal drug delivery to the […]
In December 2022, US president Joe Biden signed legislation that may change the future of research. Due to the new law, the Food and Drug Agency (FDA) is no longer obligated to ask for animal […]
Florian Ingelfinger, an immunologist at the University of Zürich, has won the Pfizer Research Award. Ingelfinger was studying Multiple Sclerosis (MS), an autoimmunity disease causing inflammatory reactions in the central nervous system and the spinal […]
We are proud to welcome our new members. Read on to learn about the research expertise they contribute to our community. Prof. Angelika Steger, Group Leader Institute of Theoretical Computer Science, ETH Zurich Neurons exhibit […]
We congratulate Christelle Le Foll, Katrin Frauenknecht, and Margarita G. Todorova on their inaugural lectures. In November, Christelle Le Foll talked about “Impact of fat on the brain: good or bad?“. In December, Katrin Frauenknecht […]
The 3rd Konrad Akert lecture will be held by Li-Huei Tsai from the Massachusetts Institute of Technology. Li-Huei is an outstanding scientist who made a number of seminal discoveries in the context of memory formation […]
Antibodies against specific target molecules or structures in the brain and spinal cord are currently reaching the stage of clinical application for several neurological diseases like Alzheimer’s, Parkinson’s, Multiple Sclerosis, and spinal cord injury. How […]
Two doctoral theses at the ZNZ PhD Program in Neuroscience were awarded the ETH medal 2022. We congratulate the award winners and wish them all the best for their future research careers. The medal winners […]
Amyloid-β pathology is believed to be a key component underlying Alzheimer’s Disease. However, most treatments that target amyloid-β have failed clinical trials. To systematically evaluate these treatments and possible reasons for failure, Adriano Aguzzi (USZ), […]
Copyright ©2023 Neuroscience Center Zurich | Web Design by catta